VanEck Pharmaceutical ETF Rating $90.82 -0.57 (-0.62%) (As of 11/4/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy2.69Holdings in PPH have an aggregate rating of Moderate Buy based on 245 analyst ratings issued in the past year covering 24 companies (95.8% of the portfolio).PPH Aggregate Price Target$107.1417.97% UpsideHigh Prediction$123.21Average Prediction$107.14Low Prediction$88.77Holdings in PPH have an aggregate price target of $107.14 and a range of $88.77 to $123.21 covering 24 companies (95.8% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.33%LLYEli Lilly and Company$806.14-1.6%4.9808 of 5 stars2.84$1,008.41 25.1%19Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision8.27%NVONovo Nordisk A/S$109.72-2.0%4.4671 of 5 stars2.86$144.50 31.7%7Upcoming EarningsAnalyst Upgrade6.82%JNJJohnson & Johnson$158.24-1.2%4.9751 of 5 stars2.54$175.93 11.2%136.04%ABBVAbbVie$200.47-1.5%4.8436 of 5 stars2.84$201.00 0.3%20Earnings ReportDividend IncreaseAnalyst UpgradeAnalyst Revision5.14%NVSNovartis$110.52+1.1%2.2199 of 5 stars1.88$121.50 9.9%8Earnings Report5.11%BMYBristol-Myers Squibb$55.45+2.1%4.5228 of 5 stars1.93$53.00 -4.4%14Earnings ReportAnalyst ForecastAnalyst Revision4.97%AZNAstraZeneca$71.43+0.0%4.3923 of 5 stars2.91$89.75 25.6%11Options Volume4.91%MRKMerck & Co., Inc.$101.870.0%4.9986 of 5 stars2.88$129.93 27.5%17Earnings ReportAnalyst Forecast4.65%ZTSZoetis$175.18-3.7%4.9836 of 5 stars3.10$221.44 26.4%10News CoverageGap Down4.64%CORCencora$233.89-0.2%4.9602 of 5 stars2.70$259.44 10.9%10Upcoming EarningsPositive News4.60%MCKMcKesson$525.94-0.1%4.9538 of 5 stars2.75$610.86 16.1%16Upcoming EarningsDividend Announcement4.55%PFEPfizer$27.76-1.2%4.9851 of 5 stars2.60$33.58 21.0%15Earnings ReportAnalyst Revision4.44%HLNHaleon$9.76+0.3%3.6256 of 5 stars3.00$10.95 12.2%6News Coverage4.31%SNYSanofi$52.95-0.6%2.5245 of 5 stars2.75$57.50 8.6%44.06%GSKGSK$36.97+0.2%4.3771 of 5 stars2.78$50.00 35.2%9Dividend Increase3.78%TEVATeva Pharmaceutical Industries$18.64+1.0%1.4641 of 5 stars2.78$19.67 5.5%9Upcoming Earnings1.88%VTRSViatris$11.45-1.5%2.532 of 5 stars2.50$14.00 22.3%2Upcoming Earnings1.07%CTLTCatalent$58.69-0.1%3.2537 of 5 stars2.00$59.83 1.9%80.97%JAZZJazz Pharmaceuticals$109.41-0.9%4.7796 of 5 stars2.79$173.43 58.5%14Upcoming Earnings0.60%OGNOrganon & Co.$16.92-6.4%4.8926 of 5 stars2.50$21.33 26.1%4Earnings ReportDividend AnnouncementHigh Trading Volume0.56%ELANElanco Animal Health$12.56-0.3%4.1593 of 5 stars2.43$17.00 35.4%7Upcoming Earnings0.43%PRGOPerrigo$25.41-2.6%4.8684 of 5 stars2.75$37.00 45.6%4Upcoming EarningsDividend Announcement0.40%BHCBausch Health Companies$9.26-5.3%3.8887 of 5 stars2.00$7.75 -16.3%7Earnings ReportAnalyst Forecast0.22%PDCOPatterson Companies$21.04+0.9%4.9637 of 5 stars2.27$28.30 34.5%11 This page (NASDAQ:PPH) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPH Stock Alerts